You need to be logged in to view this video

A Biotech Company Developing a Major Medical Breakthrough: Learn About Opportunities for Pre-IPO Investments for Qualified Investors

Released on Tuesday, September 15, 2020BIOTECH
Zhittya Genesis Medicine is a biotech company advancing, through FDA-authorized clinical trials, a biological drug that triggers angiogenesis (growth of new blood vessels) in damaged or ischemic tissues. This breakthrough medical treatment has the potential to reverse diseases which cause suffering and death for over 50% of all adults worldwide, including heart disease, strokes, diabetic foot ulcers, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. Zhittya believes its drug could extend human life an additional 20 to 30 years with good quality health.

Jack Jacobs
Zhittya Genesis Medicine, Inc., President and Chief Scientific Officer

Trending Now


Filter By Category
Filter By Keywords
Loading...
I